• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Brca2基因发生截短突变的小鼠中的胸腺淋巴瘤

Thymic lymphomas in mice with a truncating mutation in Brca2.

作者信息

Friedman L S, Thistlethwaite F C, Patel K J, Yu V P, Lee H, Venkitaraman A R, Abel K J, Carlton M B, Hunter S M, Colledge W H, Evans M J, Ponder B A

机构信息

Cancer Research Campaign, Human Cancer Genetics Research Group, Cambridge University, Addenbrooke's Hospital, United Kingdom.

出版信息

Cancer Res. 1998 Apr 1;58(7):1338-43.

PMID:9537225
Abstract

Inherited mutations in the BRCA2 gene predispose women to breast and ovarian cancer. We created a mutation in the mouse Brca2 gene that terminates translation in exon 11 at 45% of the normal transcript length. Ninety % of Brca2(tm1Cam) homozygous mutant mice die prenatally or perinatally. The location of the Brca2(tm1Cam) mutation differs from those reported previously, and this phenotype suggests a correlation with genotype analogous to that previously reported in humans. Although heterozygote mice have remained free of tumors for 10 months, Brca2(tm1Cam) homozygous mutants that survived to adulthood died with thymic lymphomas between 12 and 14 weeks of age.

摘要

BRCA2基因的遗传性突变使女性易患乳腺癌和卵巢癌。我们在小鼠Brca2基因中制造了一个突变,该突变在外显子11处终止翻译,导致转录本长度仅为正常长度的45%。90%的Brca2(tm1Cam)纯合突变小鼠在产前或围产期死亡。Brca2(tm1Cam)突变的位置与先前报道的不同,这种表型表明其与基因型之间存在类似于先前在人类中报道的相关性。尽管杂合子小鼠在10个月内未发生肿瘤,但存活至成年的Brca2(tm1Cam)纯合突变体在12至14周龄时死于胸腺淋巴瘤。

相似文献

1
Thymic lymphomas in mice with a truncating mutation in Brca2.Brca2基因发生截短突变的小鼠中的胸腺淋巴瘤
Cancer Res. 1998 Apr 1;58(7):1338-43.
2
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.携带截短型Brca2突变的小鼠的肿瘤发生及DNA修复缺陷
Nat Genet. 1997 Dec;17(4):423-30. doi: 10.1038/ng1297-423.
3
Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.携带Brca1或Brca2突变的杂合子小鼠在对己烯雌酚的反应中表现出不同的乳腺和卵巢表型。
Cancer Res. 2000 Jul 1;60(13):3461-9.
4
The Brca1 and Brca2 proteins and tumor pathogenesis.乳腺癌1号基因和乳腺癌2号基因蛋白与肿瘤发病机制
Anticancer Res. 1999 Jul-Aug;19(4B):2853-61.
5
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.基于人群的BRCA1和BRCA2中一组特定蛋白质截短突变的乳腺癌平均年龄特异性累积风险估计。澳大利亚乳腺癌家族研究。
Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):741-7.
6
A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.在一个乳腺癌/卵巢癌家族中,一个大片段缺失破坏了BRCA2基因的外显子3转录激活结构域。
Cancer Res. 1998 Apr 1;58(7):1372-5.
7
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.BRCA2基因中的一种常见变异与乳腺癌风险和产前生存能力均有关联。
Nat Genet. 2000 Nov;26(3):362-4. doi: 10.1038/81691.
8
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.对BRCA1和BRCA2基因的突变分析发现,在16个佛兰芒乳腺癌和/或卵巢癌家族中的6个家族中存在新的和复发性突变,但在12例早发性散发性患者中未发现此类突变。简短编号224中的突变。在线版。
Hum Mutat. 1999;13(3):256. doi: 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M.
9
Lessons learned from BRCA1 and BRCA2.从BRCA1和BRCA2中吸取的教训。
Oncogene. 2000 Dec 11;19(53):6159-75. doi: 10.1038/sj.onc.1203968.
10
Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.中国卵巢癌患者中BRCA1和BRCA2基因的突变分析鉴定出6种新的种系突变。
Hum Mutat. 2000 Jul;16(1):88-9. doi: 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G.

引用本文的文献

1
Druggable Molecular Networks in -Mutated Breast Cancer.-突变乳腺癌中的可药物作用分子网络
Biology (Basel). 2025 Mar 2;14(3):253. doi: 10.3390/biology14030253.
2
FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk.家族事务:剖析遗传因素对多发性骨髓瘤风险的影响
Semin Hematol. 2025 Feb;62(1):11-19. doi: 10.1053/j.seminhematol.2024.11.006. Epub 2024 Nov 30.
3
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.BRCA1和BRCA2:从癌症易感性到合成致死性
Genes Dev. 2025 Jan 7;39(1-2):86-108. doi: 10.1101/gad.352083.124.
4
DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces.DMC1 和 RAD51 通过两个独立的界面结合 BRCA2 的 FxxA 和 FxPP 基序。
Nucleic Acids Res. 2024 Jul 8;52(12):7337-7353. doi: 10.1093/nar/gkae452.
5
BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair.BRCA2 主要通过其在同源定向修复中的作用来促进基因组完整性和治疗抵抗。
Mol Cell. 2024 Feb 1;84(3):447-462.e10. doi: 10.1016/j.molcel.2023.12.025. Epub 2024 Jan 19.
6
PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation.PP2A 抑制通过纺锤体组装检查点的重新激活导致 BRCA2 突变型前列腺癌模型中的合成致死。
J Clin Invest. 2024 Jan 2;134(1):e172137. doi: 10.1172/JCI172137.
7
A transcriptional response to replication stress selectively expands a subset of Brca2-mutant mammary epithelial cells.复制压力诱导的转录反应选择性扩增了一组特定的 Brca2 突变型乳腺上皮细胞。
Nat Commun. 2023 Aug 25;14(1):5206. doi: 10.1038/s41467-023-40956-w.
8
Germline loss-of-function and mutations and risk of hematopoietic malignancies.生殖系功能丧失、突变与造血系统恶性肿瘤风险
Haematologica. 2024 Jan 1;109(1):351-356. doi: 10.3324/haematol.2022.281580.
9
Genetically engineered mouse models for hereditary cancer syndromes.遗传性癌症综合征的基因工程小鼠模型。
Cancer Sci. 2023 May;114(5):1800-1815. doi: 10.1111/cas.15737. Epub 2023 Feb 14.
10
BRCA2 Promotes Spontaneous Homologous Recombination In Vivo.BRCA2在体内促进自发同源重组。
Cancers (Basel). 2021 Jul 21;13(15):3663. doi: 10.3390/cancers13153663.